MedPath

Tomosynthesis (TS) Versus Ultrasonography (US) in Women With Dense Breast

Not Applicable
Conditions
Breast Cancer
Interventions
Device: 3D mammography (Tomosynthesis)
Device: Ultrasound
Registration Number
NCT02066142
Lead Sponsor
University of Genova
Brief Summary

Hypothesis The study aims to demonstrate at least equivalence, or non-significant difference between TS and US in women with dense breast screened negative at 2D Mammography.

If the equivalence between TS and US will be demonstrated, US may be substituted by TS with great benefits for the patients and for the healthcare resources.

Aims

1. Assess if TS may detect additional cancers in dense breast that approximate US detection capability but with less false positive findings than US.

2. If TS detects new cancers in dense breast similarly to US (approximate rate or marginally lower rate), evaluate the the true positive/false positive ratio.

3. Cost-analysis. In case of less false positives detected by TS, the true-positive / false positive trade-off might be strongly in favour of TS with a great potential of costs reduction.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
4000
Inclusion Criteria
  • Asymptomatic subjects <50 years of age presenting for mammography, with the exception of those that, on previous mammograms are found to have breast density 1-2 according to the Breast Imaging Reporting and Data System (BIRADS D1-2). - Asymptomatic subjects ≥ 50 years of age who request mammography and have breast density BIRADS 3-4.
  • No history of breast cancer - Written informed consent
Read More
Exclusion Criteria
  • Pregnant and breast feeding women
  • Unable to tolerate breast compression
  • Breast implants
  • Unable to understand or execute written informed consent
  • Unable or unwilling to agree to follow-up during observation period
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Tomosynthesis3D mammography (Tomosynthesis)Tomosynthesis will be compared to Ultrasound
UltrasoundUltrasoundUltrasound (sensitivity and specificity) will be compared to Tomosynthesis
Primary Outcome Measures
NameTimeMethod
1) Sensitivity of TSup to 36 months

We want to verify if TS may detect additional cancers in dense breast that approximate US detection capability but with less false positive findings than US.

Secondary Outcome Measures
NameTimeMethod
2) Specificity of TSup to 36 months

If TS detects new cancers in dense breast similarly to US (approximate rate or marginally lower rate), evaluate the the true positive/false positive ratio.

Trial Locations

Locations (1)

UNIGE

🇮🇹

Genova, Italy

© Copyright 2025. All Rights Reserved by MedPath